Perceptive Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Perceptive Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-40,062	Closed	-$719K	–	169
2017 Q4	$719K	Buy	+40,062	New	+$493K	0.02%	108
2017 Q1	–	Sell	-30,694	Closed	-$416K	–	227
2016 Q4	$416K	Sell	30,694 -10,402	-25%	-$145K	0.03%	130
2016 Q3	$506K	Hold	41,096	–	–	0.03%	125
2016 Q2	$451K	Buy	41,096 +40,337	+5,314%	+$452K	0.03%	129
2016 Q1	$8K	Hold	759	–	–	﹤0.01%	167
2015 Q4	$13K	Sell	759 -7,146	-90%	-$128K	﹤0.01%	152
2015 Q3	$157K	Buy	+7,905	New	+$181K	0.01%	145

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Perceptive Advisors's SCMP Position: Q1 2018 in Review

Perceptive Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 40,062 shares — an estimated $719K sold.

Perceptive Advisors first reported a position in SCMP in Q3 2015 and held it in 7 quarters. The position peaked at $719K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Perceptive Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Perceptive Advisors sold 40,062 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $719K.
Perceptive Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 7 quarters.
Perceptive Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $719K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Perceptive Advisors's 13F filing for Q1 2018, filed 15 May 2018.